Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery

Iranian Journal of Pharmaceutical Research

Volumn 14, Issue 1, 2015, Pages 27-34

  Mohseni, Meysam ^a   Gilani, Kambiz ^b   Mortazavi, Seyed Alireza ^a,c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug delivery; Drug release; Drug loading; Mesoporous silica nanoparticles; Rifampin

Indexed keywords

NANOPARTICLE; RIFAMPICIN; SILICA NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CENTRIFUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PARTICLE SIZE; PULMONARY DRUG DELIVERY SYSTEM; SCANNING ELECTRON MICROSCOPY; TEMPERATURE; ULTRAVIOLET RADIATION; X RAY DIFFRACTION;

EID: 84911465914     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Benita S (ed.), Microencapsulation. Drugs and the Pharmaceutical sciences. Marcel Dekker, New York (1996).
2. Charman WN. Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts. J. Pharm. Sci. (2000) 89: 967-978.
3. Lian T and Ho RJ. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. (2001) 90: 667-680.
4. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release(2001) 73: 137-172.
5. Amjadi I, Rabiee M and Hosseini M-S. Anticancer activity of nanoparticles based on PLGA and its Co-polymer: In-vitro evaluation. Iran. J. Pharm. Res. (2013) 12: 11.
6. Unger K, Rupprecht H, Valentin B and Kircher W. The use of porous and surface modifed silicas as drug delivery and stabilizing agents. Drug Dev. Indust. Pharm. (1983) 9: 69-91.
7. Uglea C V, Albu I, Vatajanu A, Croitoru M, Antoniu S, Panaitescu L and Ottenbrite R M. Drug delivery systems based on inorganic materials: I. Synthesis and characterization of a zeolite-cyclophosphamide system. J. Biomater. Sci. Polym. Ed. (1994) 6: 633-637.
8. Kortesuo P, Ahola M, Kangas M, Kangasniemi I, Yli-Urpo A and Kiesvaara J. In-vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery. Int. J. Pharm. (2000) 200: 223-229.
9. Wang S. Ordered mesoporous materials for drug delivery. Microporous and Mesoporous Materials(2009) 117: 1-9.
10. Chen J-F, Ding H-M, Wang J-X and Shao L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials(2004) 25: 723-727.
11. He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, Guo L and Chen Y. The effect of PEGylation of mesoporous silica nanoparticles on nonspecifc binding of serum proteins and cellular responses. Biomaterials(2010) 31: 1085-1092.
12. Huang X, Teng X, Chen D, Tang F and He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials(2010) 31: 438-448.
13. Kilpeläinen M, Riikonen J, Vlasova M A, Huotari A, Lehto V P, Salonen J, Herzig K H and Järvinen K. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. J. Controlled Release(2009) 137: 166-170.
14. Lee C-H, Lin T-S and Mou C-Y. Mesoporous materials for encapsulating enzymes. Nano Today(2009) 4: 165-179.
15. Li Z-Z, Wen L-X, Shao L and Chen J-F. Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J. Controlled Release(2004) 98: 245-254.
16. Salonen J, Laitinen L, Kaukonen A M, Tuura J, Björkqvist M, Heikkilä T, Vähä-Heikkilä K, Hirvonen J and Lehto V P. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J. Controlled Release(2005) 108: 362-374.
17. Slowing II, Vivero-Escoto JL, Wu C-W and Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. (2008) 60: 1278-1288.
18. Vivero-Escoto JL, Slowing II and Lin VSY. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials(2010) 31: 1325-1333.
19. Xiahui P, Qiang Z D, Peng, Qiuli D, Lini T, Feipeng J, Liu L, Liu j, Zhao C and Wang X. Sustained Release of Naproxen in a New Kind Delivery System of Carbon Nanotubes Hydrogel. Iran. J. Pharm. Res. (2013) 12: 5.
20. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D and Qiu S. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous and Mesoporous Materials(2006) 92: 1-9.
21. Heikkila T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin DY, Hamdy MS, Mul G, Laitinen L, Kaukonen AM, Hirvonen J and Lehto VP. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv. (2007) 14: 337-347.
22. Wen LX, Ding HM, Wang JX and Chen JF. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine. J. Nanosci. Nanotechnol. (2006) 6: 3139-3144.
23. Beck-Broichsitter M, Gauss J, Packhaeuser CB, Lahnstein K, Schmehl T, Seeger W, Kissel T and Gessler T. Pulmonary drug delivery with aerosolizable nanoparticles in an ex-vivo lung model.Int. J. Pharm. (2009) 367: 169-178.
24. Fent K, Weisbrod C J, Wirth-Heller A and Pieles U. Assessment of uptake and toxicity of fuorescent silica nanoparticles in zebrafsh (Danio rerio) early life stages. Aquat Toxicol. (2010) 100: 218-228.
25. Yu K, Grabinski C, Schrand A, Murdock R, Wang W, Gu B, Schlager J and Hussain S. Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J. Nanoparticle Res. (2009) 11: 15-24.
26. Liu T, Li L, Teng X, Huang X, Liu H, Chen D, Ren J, He J and Tang F. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials(2011) 32: 1657-1668.
27. Qiao Z-A, Zhang L, Guo M, Liu Y and Huo Q. Synthesis of mesoporous silica nanoparticles via controlled hydrolysis and condensation of silicon alkoxide. Chem. Materials(2009) 21: 3823-3829.
28. Ciesla U and Schuth F. Ordered mesoporous materials. Microporous and Mesoporous Materials(1999) 27: 131-149.
29. SING KSW. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Provisional). Pure. Appl. Chem. (1982) 54: 2201-2218.
30. Manzano M, Aina V, Areán C O, Balas F, Cauda V, Colilla M, Delgado MR and Vallet-Regí M. Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization. Chem. Engin. J. (2008) 137: 30-37.
31. Cauda V, Schlossbauer A and Bein T. Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol). Microporous and Mesoporous Materials(2010) 132: 60-71.
32. Charnay C, Begu S, Tourne-Peteilh C, Nicole L, Lerner DA and Devoisselle JM. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. (2004) 57: 533-540.